UT

PF3D7_0704600 (UT/PfUT) is a HECT-type E3 ubiquitin ligase of Plasmodium falciparum that regulates intraerythrocytic cell cycle progression and merozoite invasion and functions within the parasite egress pathway (PMID:31797898, PMID:32669539). Overexpression of PfUT lengthens the S/M phase of the intraerythrocytic developmental cycle and reduces merozoite invasion efficiency, establishing it as a positive controller of cell cycle timing and invasion (PMID:31797898). Phosphoproteomic and chemical-genetic analyses place PfUT downstream of the protein phosphatase PfPP1 in the pathway governing parasite egress from host erythrocytes, indicating its activity is phosphoregulated (PMID:32669539). Genetically, PfUT contributes in a background-dependent manner to quinine and quinidine sensitivity, with episomal expression producing moderate (~2-fold) shifts in IC50 in a subset of strains (PMID:24830312). The P. yoelii ortholog (Pyheul) similarly acts in a virulence-regulatory pathway, where allele-dependent differences and altered expression modulate parasitemia and host mortality (PMID:28790316). The specific ubiquitination substrates of PfUT, its structural basis, and the mechanistic link between its ligase activity and each phenotype have not been characterized in the available corpus.

1. 2014 Medium

   Establishing whether PF3D7_0704600 contributes to antimalarial drug response addressed whether this HECT ligase has any measurable phenotypic role in P. falciparum.

   Evidence QTL analysis of a genetic cross plus episomal transfection with IC50 measurement across multiple genetic backgrounds

   PMID:24830312

   Open questions at the time

   • Effect is moderate (~2-fold) and only seen in a subset of genetic backgrounds
   • The molecular basis linking ubiquitin ligase activity to quinine/quinidine sensitivity is unknown
   • No substrate or interacting partner identified for this drug phenotype
2. 2017 Medium

   Analysis of the P. yoelii ortholog Pyheul tested whether this HECT ligase influences parasite growth and virulence in an in vivo rodent malaria model.

   Evidence Genetic cross of P. yoelii strains, genome-wide QTL scan, and allelic exchange with parasitemia and host-mortality readouts

   PMID:28790316

   Open questions at the time

   • Findings are in the P. yoelii ortholog, not PF3D7_0704600 itself
   • The allele-specific molecular differences driving virulence are not defined
   • No ubiquitination substrate linked to the virulence phenotype
3. 2019 Medium

   Defining the cellular consequence of altered PfUT levels revealed a direct role in intraerythrocytic cell cycle timing and merozoite invasion, moving beyond drug-response association.

   Evidence glmS ribozyme-mediated overexpression (2.5-fold), cell cycle staging, invasion efficiency assays, and partial glucosamine rescue in P. falciparum

   PMID:31797898

   Open questions at the time

   • Phenotype derives from overexpression rather than loss-of-function
   • The substrates ubiquitinated by PfUT to control S/M phase are unidentified
   • Mechanistic link between invasion defect and cell cycle lengthening not resolved
4. 2020 Medium

   Positioning PfUT downstream of PfPP1 established that its activity is embedded in the phosphoregulated egress signaling pathway.

   Evidence Phosphoproteomic and chemical-genetic analysis of PfPP1 in P. falciparum

   PMID:32669539

   Open questions at the time

   • PfUT is one of two identified PfPP1 targets; direct regulation not fully dissected in the abstract
   • Whether PfPP1 dephosphorylates PfUT directly and how this modulates ligase activity is unknown
   • The egress-relevant substrates of PfUT are not identified

• The ubiquitination substrates of PfUT, its catalytic and structural basis, and how its HECT ligase activity mechanistically drives cell cycle timing, egress, invasion, and drug response remain unresolved.
• No direct ubiquitination substrate identified
• No structural or biochemical characterization of ligase activity
• Loss-of-function phenotype in P. falciparum not defined